Skip to main content
Top
Published in: BMC Infectious Diseases 1/2019

Open Access 01-12-2019 | Human Immunodeficiency Virus | Research article

Predictors of virological treatment failure among adult HIV patients on first-line antiretroviral therapy in Woldia and Dessie hospitals, Northeast Ethiopia: a case-control study

Authors: Mohammed Ahmed, Hailu Merga, Habtemu Jarso

Published in: BMC Infectious Diseases | Issue 1/2019

Login to get access

Abstract

Background

Virological treatment failure is a problem that a Human Immune Virus patient faces after starting treatment due to different factors. However, there were few studies done on the predictors of virological treatment failure among adult patients on first-line antiretroviral therapy in Ethiopia in general, and no study was done in the study area in particular. Therefore, the aim of the study was to identify predictors of virological treatment failure among adult patients on first-line antiretroviral therapy in Woldiya and Dessie Hospitals, Northeast Ethiopia.

Method

Hospital based case–control study was conducted in Woldia and Dessie Hospitals from from 12 August 2016–28 February 2018 on 154 cases and 154 controls among adult patients on first-line antiretroviral treatment. All cases were included and comparable controls were selected using stratified random sampling technique. Data were collected by document review using checklists and entered into Epidata version 3.1 and analyzed by SPSS version 21.
Multivariable logistic regression analysis was done to identify the independent predictors of virological treatment failure.

Results

In this study, statistically higher odds of virological failure was observed among patients who had current CD4 T-cell count of < 200 mm3 (AOR = 2.4, 95% CI: 1.35, 4, 18) compared withCD4 T-cell count of > 200 mm3, current body mass index(BMI) < 16 kg/m2 (AOR = 4.2, 95% CI:1.85, 9.51) compared with BMI > 18.5 kg/m2, BMI between 16 and 18.5 kg/m2 (AOR = 3.72, 95% CI: 1.75, 7.92) versus BMI > 18.5 kg/m2, poor adherence to antiretroviral therapy (AOR = 5.4, 95% CI: 2.95, 9.97) compared with good adherence.

Conclusion

This study showed that low current CD4 T-cell count and body mass index, as well as poor adherence for ART treatment predicts virological failure. Therefore, deliberate efforts are urgently needed in HIV care through improving their nutritional status by enhancing nutritional education and support, and by strengthening enhanced adherence counseling.
Literature
1.
go back to reference WHO. HIV drug resistance report 2017. In: Geneva; 2017. WHO. HIV drug resistance report 2017. In: Geneva; 2017.
2.
go back to reference UNAIDS. Ending AIDS Progress towards the 90–90–90 targets. 2017; UNAIDS. Ending AIDS Progress towards the 90–90–90 targets. 2017;
3.
go back to reference AIDSinfo. Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents. 2016. AIDSinfo. Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents. 2016.
4.
go back to reference WHO. Consolidated Guidelines on the use of Antiretroviral Drugs for treating and preventing HIV Infection Recommendations for a Public Health Approach. 2nd edi. Geneva; 2016. WHO. Consolidated Guidelines on the use of Antiretroviral Drugs for treating and preventing HIV Infection Recommendations for a Public Health Approach. 2nd edi. Geneva; 2016.
5.
go back to reference FDREMOH. National Guidelines for comprehensive HIV prevention. In: Care and treatment; 2014. FDREMOH. National Guidelines for comprehensive HIV prevention. In: Care and treatment; 2014.
6.
go back to reference WHO. Tackling HIV Drug Resistance : Trends , Guidelines And Global Action. 2017;1–4. WHO. Tackling HIV Drug Resistance : Trends , Guidelines And Global Action. 2017;1–4.
7.
go back to reference Leng X, Liang S, Ma Y, Dong Y, Kan W, Goan D, et al. HIV virological failure and drug resistance among injecting drug users receiving fi rst-line ART in China. BMJ open. 2014:1–8. Leng X, Liang S, Ma Y, Dong Y, Kan W, Goan D, et al. HIV virological failure and drug resistance among injecting drug users receiving fi rst-line ART in China. BMJ open. 2014:1–8.
8.
go back to reference Jobanputra K, Parker LA, Azih C, Okello V, Maphalala G, Kershberger B, et al. Factors Associated with Virological Failure and Suppression after Enhanced Adherence Counselling , in Children , Adolescents and Adults on Antiretroviral Therapy for HIV in Swaziland. 2015;450:1–12. Jobanputra K, Parker LA, Azih C, Okello V, Maphalala G, Kershberger B, et al. Factors Associated with Virological Failure and Suppression after Enhanced Adherence Counselling , in Children , Adolescents and Adults on Antiretroviral Therapy for HIV in Swaziland. 2015;450:1–12.
9.
go back to reference Hassan AS, Nabwera HM, Mwaringa SM, Obonyo CA, Sanders EJ, De WTFR, et al. HIV-1 virologic failure and acquired drug resistance among first-line antiretroviral experienced adults at a rural HIV clinic in coastal Kenya : a cross-sectional study. AIDS research and therapy. 2014;11(1):9.CrossRef Hassan AS, Nabwera HM, Mwaringa SM, Obonyo CA, Sanders EJ, De WTFR, et al. HIV-1 virologic failure and acquired drug resistance among first-line antiretroviral experienced adults at a rural HIV clinic in coastal Kenya : a cross-sectional study. AIDS research and therapy. 2014;11(1):9.CrossRef
10.
go back to reference Pou C, Maculuve S, Ceden S, Luis L, Rodrı J, Clotet B, et al. Determinants of virological failure and antiretroviral drug resistance in Mozambique. J Antimicrobial Chemother. 2017:2639–47. Pou C, Maculuve S, Ceden S, Luis L, Rodrı J, Clotet B, et al. Determinants of virological failure and antiretroviral drug resistance in Mozambique. J Antimicrobial Chemother. 2017:2639–47.
11.
go back to reference Vella C, Eymard-duvernay S, Sica J, Makosso L, Mongo AD, Boue V, et al. Short report Virological failure rates and HIV-1 drug resistance patterns in patients on first-line antiretroviral treatment in semirural and rural Gabon. J Int AIDS Soc. 2012;(Vl):17985. Vella C, Eymard-duvernay S, Sica J, Makosso L, Mongo AD, Boue V, et al. Short report Virological failure rates and HIV-1 drug resistance patterns in patients on first-line antiretroviral treatment in semirural and rural Gabon. J Int AIDS Soc. 2012;(Vl):17985.
12.
go back to reference Ndahimana A, Riedel DJ, Mwumvaneza M, Sebuhoro D, Uwimbabazi JC, Kubwimana M, et al. Drug resistance mutations after the first 12 months on antiretroviral therapy and determinants of virological failure in Rwanda. Tropical Med Int Health. 2016;21(7):928–35.CrossRef Ndahimana A, Riedel DJ, Mwumvaneza M, Sebuhoro D, Uwimbabazi JC, Kubwimana M, et al. Drug resistance mutations after the first 12 months on antiretroviral therapy and determinants of virological failure in Rwanda. Tropical Med Int Health. 2016;21(7):928–35.CrossRef
13.
go back to reference Bulage L, Ssewanyana I, Nankabirwa V, Nsubuga F, Kihembo C, Pande G, et al. Factors associated with Virological non- suppression among HIV-positive patients on antiretroviral therapy in Uganda , august 2014 – July 2015. BMC. 2017:1–11. Bulage L, Ssewanyana I, Nankabirwa V, Nsubuga F, Kihembo C, Pande G, et al. Factors associated with Virological non- suppression among HIV-positive patients on antiretroviral therapy in Uganda , august 2014 – July 2015. BMC. 2017:1–11.
14.
go back to reference Brhane BG, Nibret E, Abay GK. HIV/AIDS treatment failure and its determinant factors among first line HAART patients at Felege-Hiwot referral hospital , Bahir Dar , northwest. AIDS Clin Res. 2017;8(11). Brhane BG, Nibret E, Abay GK. HIV/AIDS treatment failure and its determinant factors among first line HAART patients at Felege-Hiwot referral hospital , Bahir Dar , northwest. AIDS Clin Res. 2017;8(11).
15.
go back to reference Gebreab B, Barnabas G, Sibhatu MK, Berhane Y. Antiretroviral Therapy Program in Ethiopia Benefits From Virology Treatment Monitoring. Ethiopian J Health Sci. 2017:10–1. Gebreab B, Barnabas G, Sibhatu MK, Berhane Y. Antiretroviral Therapy Program in Ethiopia Benefits From Virology Treatment Monitoring. Ethiopian J Health Sci. 2017:10–1.
16.
go back to reference Ayalew MB, Kumilachew D, Belay A, Getu S, Teju D, Endale D, Tsegaye Y, Wale Z. First-line antiretroviral treatment failure and associated factors in HIV patients at the University of Gondar Teaching Hospital, Gondar, Northwest Ethiopia. HIV/AIDS (Auckland, NZ). 2016;8:141–6. Ayalew MB, Kumilachew D, Belay A, Getu S, Teju D, Endale D, Tsegaye Y, Wale Z. First-line antiretroviral treatment failure and associated factors in HIV patients at the University of Gondar Teaching Hospital, Gondar, Northwest Ethiopia. HIV/AIDS (Auckland, NZ). 2016;8:141–6.
17.
go back to reference Bayu B, Tariku A, Bulti AB, Habitu YA, Derso T, Teshome DF. Determinants of virological failure among patients on highly active antiretroviral therapy in University of Gondar Referral Hospital , Northwest Ethiopia. HIV/AIDS (Auckland, NZ). 2017:153–9. Bayu B, Tariku A, Bulti AB, Habitu YA, Derso T, Teshome DF. Determinants of virological failure among patients on highly active antiretroviral therapy in University of Gondar Referral Hospital , Northwest Ethiopia. HIV/AIDS (Auckland, NZ). 2017:153–9.
18.
go back to reference Bezabhe WM, Chalmers L, Bereznicki LR, Peterson GM. Adherence to Antiretroviral Therapy and Virologic Failure. Medicine. 2016;95(15):1–9.CrossRef Bezabhe WM, Chalmers L, Bereznicki LR, Peterson GM. Adherence to Antiretroviral Therapy and Virologic Failure. Medicine. 2016;95(15):1–9.CrossRef
19.
go back to reference Ramadhani HO, Thielman NM, Landman KZ, Ndosi EM, Gao F, Kirchherr JL, et al. Predictors of Incomplete Adherence , Virologic Failure , and Antiviral Drug Resistance among HIV-Infected Adults Receiving Antiretroviral Therapy in Tanzania. Clin Infect Dis. 2017;45:1492–8.CrossRef Ramadhani HO, Thielman NM, Landman KZ, Ndosi EM, Gao F, Kirchherr JL, et al. Predictors of Incomplete Adherence , Virologic Failure , and Antiviral Drug Resistance among HIV-Infected Adults Receiving Antiretroviral Therapy in Tanzania. Clin Infect Dis. 2017;45:1492–8.CrossRef
20.
go back to reference Bangure D, Mungati M, Chemhuru M. Factors associated with human immunodeficiency virus first line treatment failure in Zvishavane District. Austin J HIV. AIDS Res. 2015;2(1):1–6. Bangure D, Mungati M, Chemhuru M. Factors associated with human immunodeficiency virus first line treatment failure in Zvishavane District. Austin J HIV. AIDS Res. 2015;2(1):1–6.
21.
go back to reference Davey DJ, Abrahams Z. Factors associated with unsuppressed viral load in HIV-1 infected patients on 1 st line antiretroviral therapy in South Africa. Int J STD AIDS. 2017;(6):603–10. Davey DJ, Abrahams Z. Factors associated with unsuppressed viral load in HIV-1 infected patients on 1 st line antiretroviral therapy in South Africa. Int J STD AIDS. 2017;(6):603–10.
22.
go back to reference Izudi J, Alioni S, Kerukadho E, Ndungutse D. Virological failure reduced with HIV- serostatus disclosure , extra baseline weight and rising CD4 cells among HIV-positive adults in northwestern Uganda. BMC Infect Dis [Internet]. 2016;1(8) Available from: https://doi.org/10.1186/s12879-016-1952-x. Izudi J, Alioni S, Kerukadho E, Ndungutse D. Virological failure reduced with HIV- serostatus disclosure , extra baseline weight and rising CD4 cells among HIV-positive adults in northwestern Uganda. BMC Infect Dis [Internet]. 2016;1(8) Available from: https://​doi.​org/​10.​1186/​s12879-016-1952-x.
23.
go back to reference Duggal S, Das CT, Duggal AK. HIV and Malnutrition : Effects on Immune System. Clin Dev Immunol. 2012;2012. Duggal S, Das CT, Duggal AK. HIV and Malnutrition : Effects on Immune System. Clin Dev Immunol. 2012;2012.
24.
go back to reference Batterham M, Brown D, Garsia R. Nutritional management of HIV/AIDS in the era of highly active antiretroviral therapy : a review. Australian J Nut Diet. 2001;1:211–23. Batterham M, Brown D, Garsia R. Nutritional management of HIV/AIDS in the era of highly active antiretroviral therapy : a review. Australian J Nut Diet. 2001;1:211–23.
25.
go back to reference Nachega JB, Marconi VC, Zyl GU, Van GEM, Preiser W, Hong SY, et al. HIV treatment adherence, drug resistance. Virologic Failure: Evolving Concepts. 2016;11(2):167–74. Nachega JB, Marconi VC, Zyl GU, Van GEM, Preiser W, Hong SY, et al. HIV treatment adherence, drug resistance. Virologic Failure: Evolving Concepts. 2016;11(2):167–74.
Metadata
Title
Predictors of virological treatment failure among adult HIV patients on first-line antiretroviral therapy in Woldia and Dessie hospitals, Northeast Ethiopia: a case-control study
Authors
Mohammed Ahmed
Hailu Merga
Habtemu Jarso
Publication date
01-12-2019
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2019
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-019-3924-4

Other articles of this Issue 1/2019

BMC Infectious Diseases 1/2019 Go to the issue